Speaker
Senior Director, Xenon Pharmaceuticals
JP Gilbert, Senior Director at Xenon Pharmaceuticals, spoke at Ion Channel-Targeted Drug Development Summit (Boston, United States of America, 23–24 Sept 2026) in the session “Selective Potentiation of Nav1.1 Corrects Network Function and Disease Phenotypes in a Dravet Syndrome Model”.
23–24 Sept 2026Boston, United States of America
Professor - Molecular Physiology & Biophysics, The University of Iowa
Vice President of R&D and Operations, Navega Therapeutics
Professor of Neurobiology, Harvard Medical School
Senior Principal Scientist, Novartis
Chief Scientific Officer, QurAlis Corp.
Chief Scientific Officer, Nocion Therapeutics, Inc.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by JP Gilbert, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].